[Prevalence of conventional risk factors in patients with coronary heart disease]

Egidija Rinkūniene1, Zaneta Petrulioniene, Aleksandras Laucevicius

  • 1Center of Cardiology and Angiology, Clinics of Santariskes, Vilnius University Hospital, Santariskiu g. 2, 08661 Vilnius, Lithuania. egidija.rinkuniene@santa.lt

Insights

Most coronary heart disease patients have conventional risk factors, contrary to common belief. This study found 98% of patients had at least one risk factor, emphasizing improved prevention and lifestyle changes.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Conventional risk factors are often cited as absent in over 50% of coronary heart disease (CHD) patients.
  • This perception may lead to underestimation of traditional risk factor prevalence in CHD management.

Purpose of the Study:

  • To determine the prevalence of four conventional risk factors in patients diagnosed with coronary heart disease.
  • To assess the frequency of these risk factors, particularly in younger patient cohorts.

Main Methods:

  • Analysis of data from 606 patients hospitalized with coronary heart disease (myocardial infarction, unstable and stable angina pectoris) between 1997-2005.
  • Evaluation of the presence of hypertension, diabetes, dyslipidemia, and smoking as risk factors.

Main Results:

  • A high prevalence of at least one conventional risk factor was observed in 98% of all CHD patients.
  • Specific prevalences included: dyslipidemia (90.1%), hypertension (47.7%), smoking (24.1%), and diabetes (12.9%).
  • In younger patients (<55 years), 97.7% had at least one risk factor, with 66.5% having two or more.

Conclusions:

  • The study contradicts the notion that many CHD patients lack conventional risk factors, finding near-universal presence.
  • Conventional risk factors are highly prevalent, especially in younger individuals with CHD, underscoring the need for enhanced prevention strategies.
  • Greater emphasis on identifying and managing hypertension, diabetes, dyslipidemia, and smoking, alongside lifestyle modifications, is crucial for combating the CHD epidemic.

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
299
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
336
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
846
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
203
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
564
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
367